Single-Center Experience and Short-term Outcome With the JenaValve: A Second-Generation Transapical Transcatheter Aortic Valve Implantation Device
ConclusionsThis second-generation repositionable transcatheter aortic valve implantation device could safely and successfully be implanted with a fast learning curve, significant reduction in pressure gradients, overall clinical improvement at discharge, as well as an acceptable morbidity and mortality rate in this highest-risk patient cohort.
Source: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Original Articles Source Type: research
More News: Cardiology | Cardiovascular & Thoracic Surgery | Dialysis | Heart | Heart Attack | Heart Valve Surgery | Hemodialysis | Hemorrhagic Stroke | Intensive Care | Learning | Renal Failure | Stroke | Universities & Medical Training | Women